Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Wearing apparel – fabric – or cloth
Reexamination Certificate
2006-10-10
2006-10-10
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Wearing apparel, fabric, or cloth
C424S411000, C424S430000, C424S431000
Reexamination Certificate
active
07118759
ABSTRACT:
Effective amounts of the inhibitory compounds described herein capable of significantly reducing the production of TSST-1 are as follows: (1) compounds of Structure (I): from about 0.0001 micromoles/gram absorbent product to about 0.08 micromoles/gram absorbent product, desirably from about 0.0005 micromoles/gram of absorbent product to about 0.05 micromoles/gram of absorbent product; and (2) compounds of Structures (II) and (III): from about 0.05 micromoles/gram of absorbent product to 5 micromoles/gram of absorbent product, desirably from about 0.1 micromoles/gram of absorbent product to about 1 micromole/gram of absorbent product. Specifically, effective amounts of hexachlorophene include from about 0.00024 micromoles/gram of absorbent product to about 0.08 micromoles/gram of absorbent product, desirably from about 0.001 micromoles/gram of absorbent product to about 0.05 micromoles/gram of absorbent product. Specifically, effective amounts of triclosan include from about 0.0005 micromoles/gram of absorbent product to about 0.03 micromoles/gram of absorbent product. Specifically, effective amounts of cerulenin include from about 0.1 micromoles/gram of absorbent product to about 1 micromole/gram of absorbent product.
REFERENCES:
patent: 5547985 (1996-08-01), Brown-Skrobot et al.
patent: 5686088 (1997-11-01), Mitra et al.
patent: 6346391 (2002-02-01), Oethinger et al.
patent: 2003/0100871 (2003-05-01), Mauro et al.
patent: 2005/0113448 (2005-05-01), Syverson et al.
D'Agnolo, et al., Inhibition of fatty acid synthesis by the antibiotic cerulenin: Specific inactivation of β-ketoacyl-acyl carrier protein synthetase, Biochimica et Biophysica Acta, 1973, pp. 155-166, vol. 326.
Altenbern, R.A., Extreme sensitivity of staphylococcal enterotoxin B and C production to inhibition by cerulenin, Antimicrobial Agents and Chemotherapy, 1977, pp. 906-908, vol. 11.
Pepper, et al., Studies on the effect of inhibition of lipid biosynthesis by cerulenin on the production of staphylococcal enterotoxin A, Staphylococci and staphylococcal infections, 1981, pp. 393-396, Zbl. Bakt. Suppl. 10, Gustav-Fisher Verlag, Stuttgart, New York.
Campbell, et al., Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery, Annual Review of Microbiology, 2001, pp. 305-313, vol. 55, issue 1.
Price, et al., Inhibition of β-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin, J. Biological Chemistry, 2001, pp. 6551-6559, vol. 276, No. 9.
Mehesz, Erno, Pharmaceutical Compositions for the Prevention and Treatment of Fluoralbus, 81CA:54468, 1974 (1 page).
Fast, David J., et al., Toxic Shock Syndrome-Associated Staphylococcal and Streptococcal Pyrogenic Toxins are Potent Inducers of Tumor Necrosis Factor Production, 110CA:73618, 1989 (1 page).
Gennaro, et al., Remington's Pharmaceutical Sciences, 17th ed., 1985, pp. 1498-1499.
Regoes, J., et al., Antimicrobial Specturm of Triclosan, a Broad-Spectrum Antimicrobial Agent for Topical Application, 91CA:747, 1979 (1 page).
Adesiyun, et al., “Characteristics of Staphylococcus aureus strains isolated from clinical and non-clinical human sources in Trinidad: susceptibility to bacteriophages and antimicrobial agents, and toxigenicity,” Zentralblatt fuer Bakteriologie, vol. 282, No. 4 (1995) (abstract), 124:112182.
Bory, et al., “Germicide,” 82CA:18932 (1975) (abstract).
Siddiqui, et al., “Pharmacokinetics of triclosan in rat after intravenous and intravaginal administration,” Journal of Environmental Pathology and Toxicology, vol. 2, No. 3 (1979) (abstract), 90:197346.
Suller, et al., “Triclosan and antibiotic resistance inStaphylococcus aureus,” Journal of Antimicrobial Chemotherapy, 2000, pp. 11-18, vol. 46.
Heath, et al., Inhibition of theStaphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and Hexachlorophene, Journal of Biological Chemistry, 2000, pp. 4654-4659, vol. 275, No. 7.
Proctor Richard A.
Syverson Rae Ellen
Azpuru Carlos A.
Kimberly--Clark Worldwide, Inc.
LandOfFree
Absorbent articles containing additives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Absorbent articles containing additives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Absorbent articles containing additives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640628